A process for the production of cardiomocyte-like cells from mammalian cells, comprising cultering mammalian cells in the presence of a compound of formula (I) wherein the radicals have various meanings, compounds of formula (I), wherein the radicals have various meanings and the pharmaceutical use of compounds of formula (I) for the production of cardiomyocyte-like cells from omnipotent, pluripotent or lineage committed mammalian cells and the use of thus produced cardiomyocyte-like cells for treating disorders associated with impaired function of the heart.